Company Analysis

Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Nasdaq: SHPH · Pharmaceutical Preparations · Gaithersburg, MD · filing with the SEC since 2019
Grade2.9
◀ Past 2.8● Present 1.6▶ Future 3.9
6 est.

Who runs Shuttle Pharmaceuticals Holdings, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Trasolini Ryan
Co-Chief Executive Officer. First filing Jun 2026, latest Jun 1, 2026, 0 filings in all.
Officers reporting now
3
of 10 people with a filing in the last fifteen months
Directors reporting now
7
21 people on the record since 2022
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Trasolini RyanCo-Chief Executive OfficerJun 2026Jun 1, 2026none
Liang YuyingChief Financial OfficerJan 2026Jan 12, 2026none
Lorber Timothy J.Chief Financial OfficerJun 2024Aug 12, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Liriano AngeldirectorOct 2025Oct 29, 2025none
Pathigoda Arachchige Sachin ErangadirectorOct 2025Oct 28, 2025none
Chambers Adam VdirectorSep 2025Sep 8, 2025none
Richards Steven MdirectorSep 2022Aug 13, 2025none
Nabyt OlehdirectorMar 2025Aug 12, 2025none
Scorsis GeorgedirectorMar 2025Aug 12, 2025none
Tung JosephdirectorMar 2025Aug 12, 2025none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hrt Financial LP10% ownerJun 2026Jul 15, 20265 · $500,000
Earlier names on the record11, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SHPH · research, not advice